
Deutsche Venture Capital
Description
Deutsche Venture Capital (DVC) is an independent, owner-managed venture capital and private equity firm headquartered in Munich, Germany. Established in 2000, DVC primarily focuses on investing in innovative, fast-growing companies within the DACH region, encompassing Germany, Austria, and Switzerland. The firm has carved out a niche by concentrating its investment efforts specifically on the financial services, fintech, and insurance sectors, leveraging its deep industry expertise and extensive network within these domains.
DVC targets companies that have successfully launched their products or services and are transitioning into their growth phase, typically corresponding to Series A and Series B funding rounds. The firm's typical initial investment volume per company ranges between €1 million and €5 million. This translates to approximately $1.08 million to $5.4 million, based on recent exchange rates. While these figures represent their standard first cheques, DVC also has the capacity to facilitate larger investment amounts through co-investments with its network of partners, demonstrating flexibility in supporting its portfolio companies' scaling needs.
As long-term partners, Deutsche Venture Capital emphasizes providing more than just capital. The firm actively supports its portfolio companies with strategic guidance, operational expertise, and access to its broad network of industry contacts. This hands-on approach aims to accelerate growth, foster innovation, and help companies navigate the complexities of their respective markets. DVC's commitment extends beyond financial backing, positioning itself as a crucial ally in the development and success of its ventures.
Investor Profile
Deutsche Venture Capital has backed more than 21 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 29% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in Germany, Saint-Martin (France), United States.
- Strong thematic focus on Biotechnology, Software, Manufacturing.
- Typical check size: $1.1M – $5.4M.
Stage Focus
- Series B (38%)
- Series C (24%)
- Series Unknown (19%)
- Series D (10%)
- Private Equity (5%)
- Series A (5%)
Country Focus
- Germany (57%)
- Saint-Martin (France) (10%)
- United States (10%)
- United Kingdom (10%)
- Austria (5%)
- Denmark (5%)
- Switzerland (5%)
Industry Focus
- Biotechnology
- Software
- Manufacturing
- Mobile
- Medical
- Biopharma
- Therapeutics
- Health Diagnostics
- Saas
- Industrial
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.